Filing Details

Accession Number:
0001209191-20-054209
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-07 18:34:50
Reporting Period:
2020-10-05
Accepted Time:
2020-10-07 18:34:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1769804 Augmedix Inc. NONE () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1452273 Dcm Vi, L.p. 2420 Sand Hill Road
Suite 200
Menlo Park CA 94025
Yes No Yes No
1518379 A-Fund, L.p. 2420 Sand Hill Road
Suite 200
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-05 3,064,751 $0.00 3,064,751 No 4 A Direct
Common Stock Acquisiton 2020-10-05 666,667 $3.00 3,731,418 No 4 P Direct
Common Stock Acquisiton 2020-10-05 20,007 $0.00 20,007 No 4 A Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
No 4 A Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2020-10-05 269,490 $0.00 269,490 $2.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
269,490 2029-09-02 No 4 A Direct
Footnotes
  1. On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer.
  2. These securities are held of record by DCM VI, L.P. ("DCM VI"). Jason Krikorian, a member of the Issuer's board of directors, is a general partner atDCM, which is an affiliate of DCM VI.
  3. These securities are held of record by A-Fund, L.P. ("A-Fund"). Jason Krikorian, a member of the Issuer's board of directors, is a general partnerat DCM, which is an affiliate of A-Fund.
  4. The warrants are fully vested and exerciseable.